48th week of 2016 patent applcation highlights part 24 |
Patent application number | Title | Published |
20160347792 | FLUORINATED EPOXYKETONE-BASED COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORS | 2016-12-01 |
20160347793 | Biologically Cleavable Tetrapeptide Linking Agents | 2016-12-01 |
20160347794 | ANG-(1-7) Derivative Oligopeptides and Methods for Using and Producing the Same | 2016-12-01 |
20160347795 | TEICOPLANIN ANALOGS AND USES THEREOF | 2016-12-01 |
20160347796 | METHOD FOR PRODUCING PLASTIC RAW MATERIAL FROM BLUE-GREEN ALGAE | 2016-12-01 |
20160347797 | NEISSERIA MENINGITIDIS COMPOSITION AND METHODS THEREOF | 2016-12-01 |
20160347798 | MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES AND CELL-TARGETED MOLECULES FOR DIRECT CELL KILLING AND IMMUNE STIMULATION VIA MHC CLASS I PRESENTATION AND METHODS REGARDING THE SAME | 2016-12-01 |
20160347799 | INSECTICIDAL PROTEINS FROM PLANTS AND METHODS FOR THEIR USE | 2016-12-01 |
20160347800 | SHORT PEPTIDE-BASED THERAPEUTIC AGENT AND MEDICINAL COMPOSITION INCLUDING THE SAME FOR INHIBITING ACTIVITIES OF CANCER CELLS | 2016-12-01 |
20160347801 | PEPTIDES DERIVED FROM NCAPG2 AND THEIR USE | 2016-12-01 |
20160347802 | INTERACTION OF DRAXIN AND Y-NETRINS | 2016-12-01 |
20160347803 | NUCLEOTIDE SEQUENCE AND PHARMACEUTICAL COMPOSITION BASED THEREON WITH PROLONGED VEGF TRANSGENE EXPRESSION | 2016-12-01 |
20160347804 | TAU PEPTIDES, ANTI-TAU ANTIBODIES, AND METHODS OF USE THEREOF | 2016-12-01 |
20160347805 | BIOMARKER FOR HUMAN EYES AND METHOD THEREOF | 2016-12-01 |
20160347806 | OLIGOMERIZATION DOMAIN OF P53 TO BYPASS THE DOMINANT-NEGATIVE EFFECT OF MUTANT | 2016-12-01 |
20160347807 | TARGETING P53 AND ITS DNA-BINDING DOMAIN | 2016-12-01 |
20160347808 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS | 2016-12-01 |
20160347809 | HOMOGENEOUS PREPARATIONS OF IL-31 | 2016-12-01 |
20160347810 | COMPOSITIONS AND METHODS FOR TREATING ACUTE AND CHRONIC PAIN BY LOCAL ANTAGONISM OF CGRP RECEPTORS, OR COMBINATION WITH SODIUM CHANNEL INHIBITION OR WITH ANTI-INFLAMMATORY AGENTS | 2016-12-01 |
20160347811 | PHARMACEUTICAL PREPARATION | 2016-12-01 |
20160347812 | Novel Glucagon Analogues | 2016-12-01 |
20160347813 | GLUCAGON ANALOGUES | 2016-12-01 |
20160347814 | VSTM5 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASES | 2016-12-01 |
20160347815 | PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF | 2016-12-01 |
20160347816 | POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF FOR TREATMENT OF IMMUNE RELATED DISORDERS AND CANCER | 2016-12-01 |
20160347817 | FGFR-FC Fusion Proteins and the Use Thereof | 2016-12-01 |
20160347818 | Compositions and Methods for Immunomodulation in an Organism | 2016-12-01 |
20160347819 | PROCESS FOR PRODUCING AND PURIFYING FACTOR VIII AND ITS DERIVATIVES | 2016-12-01 |
20160347820 | METHOD OF MAKING COLLAGEN POWDER FROM MARINE CARTILAGE AND SKIN | 2016-12-01 |
20160347821 | P97 FUSION PROTEINS | 2016-12-01 |
20160347822 | ADENO-ASSOCIATED VIRUS MEDIATED DELIVERY OF C1EI AS A THERAPY FOR ANGIOEDEMA | 2016-12-01 |
20160347823 | A CHROMATOGRAPHY SYSTEM AND METHOD FOR CAPTURING A BIOPOLYMER | 2016-12-01 |
20160347824 | SELECTIVE REDUCTION OF PROTEINS | 2016-12-01 |
20160347825 | OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION | 2016-12-01 |
20160347826 | AFFINITY LIGANDS AND METHODS RELATING THERETO | 2016-12-01 |
20160347827 | ANTIBODIES AGAINST F GLYCOPROTEIN OF HENDRA AND NIPAH VIRUSES | 2016-12-01 |
20160347828 | Non-HIV Vaccine Antigen from the Vaginal Microbiota Capable of Inducing a Mucosal Neutralizing Protective Antibody Response Against HIV Infection | 2016-12-01 |
20160347829 | Compositions containing antimicrobial IgY antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (OHC) microorganisms | 2016-12-01 |
20160347830 | IMMUNOGLOBULIN AGAINST THE ANTHRAX TOXIN | 2016-12-01 |
20160347831 | CAMELID SINGLE-DOMAIN ANTIBODY DIRECTED AGAINST AMYLOID BETA AND METHODS FOR PRODUCING CONJUGATES THEREOF | 2016-12-01 |
20160347832 | ANTI-TRANSTHYRETIN HUMANIZED ANTIBODY | 2016-12-01 |
20160347833 | ANTIBODY PROCESS | 2016-12-01 |
20160347834 | Anti-Podoplanin Antibody | 2016-12-01 |
20160347835 | METHOD OF INHIBITING METASTASIS OF CANCER CELLS AND MODULATING AUTOIMMUNE DISEASES USING GAL-3BP-Fc FUSION PROTEIN | 2016-12-01 |
20160347836 | TREATMENT OF HODGKIN'S LYMPHOMA USING AN ANTI-PD-1 ANTIBODY | 2016-12-01 |
20160347837 | OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION | 2016-12-01 |
20160347838 | EFFECTOR-DEFICIENT ANTI-CD32A ANTIBODIES | 2016-12-01 |
20160347839 | Antibodies Comprising Chimeric Constant Domains | 2016-12-01 |
20160347840 | Prostate Specific Membrane Antigen (PSMA) Bispecific Binding Agents and Uses Thereof | 2016-12-01 |
20160347841 | NEW MONOCLONAL ANTIBODIES AGAINST THE RECEPTOR DEC-205 OF CHICKEN DENTRITIC CELLS | 2016-12-01 |
20160347842 | PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF | 2016-12-01 |
20160347843 | ISOFORM SPECIFIC SOLUBLE FMS-LIKE TYROSINE KINASE (SFLT) BINDING AGENTS AND USES THEREOF | 2016-12-01 |
20160347844 | AGENTS THAT MODULATE RGMb-NEOGENIN-BMP SIGNALING AND METHODS OF USE THEREOF | 2016-12-01 |
20160347845 | POLYNUCLEOTIDES ENCODING AN ACTRIIB ANTIBODY | 2016-12-01 |
20160347846 | FUSION PROTEINS FOR MODULATING REGULATORY AND EFFECTOR T CELLS | 2016-12-01 |
20160347847 | Anti-OX40 Antibodies and Methods of Use Thereof | 2016-12-01 |
20160347848 | THERAPEUTIC COMBINATIONS AND METHODS FOR TREATING NEOPLASIA | 2016-12-01 |
20160347849 | ANTIBODIES AGAINST OX40 AND USES THEREOF | 2016-12-01 |
20160347850 | ANTI-CD40 ANTIBODIES AND USES THEREOF | 2016-12-01 |
20160347851 | COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES | 2016-12-01 |
20160347852 | Combination therapy of an anti-CD20 antibody with a Bcl-2 inhibitor and a MDM2 inhibitor | 2016-12-01 |
20160347853 | TLR3 BINDING AGENTS | 2016-12-01 |
20160347854 | Anti-TOSO chimeric antigen receptor and its use | 2016-12-01 |
20160347855 | PSCA: PROSTATE STEM CELL ANTIGEN AND USES THEREOF | 2016-12-01 |
20160347856 | Use of Anti-MUC1 Maytansinoid Immunoconjugate Antibody for the Treatment of Solid Tumors | 2016-12-01 |
20160347857 | ANTIBODIES REACTIVE WITH AN EPITOPE LOCATED IN THE N-TERMINAL REGION OF MUC5AC COMPRISING CYSTEINE-RICH SUBDOMAIN 2 (CYS2) | 2016-12-01 |
20160347858 | Anti Human Notch4 Antibody | 2016-12-01 |
20160347859 | DUAL TARGETING OF TAFI AND PAI-1 | 2016-12-01 |
20160347860 | ANTIBODIES THAT BIND NOVEL PCSK9 VARIANTS | 2016-12-01 |
20160347861 | REDUCED SATURATED FATTY ACID PROFILES OF RUMINANTS | 2016-12-01 |
20160347862 | Thrombin-Binding Antibody Molecules and Uses Thereof | 2016-12-01 |
20160347863 | CHIMERIC SMALL MOLECULES FOR THE RECRUITMENT OF ANTIBODIES TO CANCER CELLS | 2016-12-01 |
20160347864 | ACCEPTOR FRAMEWORK FOR CDR GRAFTING | 2016-12-01 |
20160347865 | PROTEIN COATED POLYMERIC SUBSTRATE | 2016-12-01 |
20160347866 | NOVEL ESTERIFIED CELLULOSE ETHERS OF HIGH MOLECULAR WEIGHT AND HOMOGENEITY | 2016-12-01 |
20160347867 | METHOD TO PREPARE GANODERMA LUCIDUM POLYSACCHARIDES POSSESSING ANTI-OBESITY PROPERTIES AND USES THEREOF | 2016-12-01 |
20160347868 | FUC3S4S SUBSTITUTED OLIGOGLYCOSAMINOGLYCAN AND PREPARATION METHOD THEREOF | 2016-12-01 |
20160347869 | METHOD FOR SEPARATING HYALURONAN AND QUANTIFYING ITS MOLECULAR MASS DISTRIBUTION IN BIOLOGICAL SAMPLES | 2016-12-01 |
20160347870 | POLYMER MODIFYING AGENT COMPOSITION, MODIFIED POLYMER, RUBBER COMPOSITION AND TIRE | 2016-12-01 |
20160347871 | ELECTROINITIATED POLYMERIZATION OF COMPOSITIONS HAVING A 1,1-DISUBSTITUTED ALKENE COMPOUND | 2016-12-01 |
20160347872 | LIVING RADICAL POLYMERIZATION CATALYST, AND POLYMER PRODUCTION METHOD USING SAME | 2016-12-01 |
20160347873 | METAL COMPLEX WITH A CYCLIC AMIDINE LIGAND | 2016-12-01 |
20160347874 | METHOD OF PRODUCING POLYETHYLENE AND POLYETHYLENE THEREOF | 2016-12-01 |
20160347875 | POLYMERISATION PROCESS AND POLYMERISATION UNIT COMPRISING A DEGASSING SECTION | 2016-12-01 |
20160347876 | Process for Modifying Ethylene-Based Polymers and Copolymers | 2016-12-01 |
20160347877 | ANIONIC POLYMERIZATION INITIATOR HAVING ANIONIC TERMINAL COMPRISING AMINE GROUP, PRODUCTION METHOD FOR MODIFIED CONJUGATED DIENE-BASED COPOLYMER USING SAME, AND RUBBER COMPOSITION COMPRISING MODIFIED CONJUGATED DIENE-BASED COPOLYMER PRODUCED IN ACCORDANCE THEREWITH | 2016-12-01 |
20160347878 | PROCESS FOR POLYMERIZATION IN A FLUIDIZED BED REACTOR | 2016-12-01 |
20160347879 | PRODUCTION METHOD OF (METH)ACRYLIC RESIN COMPOSITION | 2016-12-01 |
20160347880 | ZIEGLER-NATTA CATALYST SYSTEMS COMPRISING A 1,2-PHENYLENEDIOATE AS INTERNAL DONOR AND PROCESS FOR PREPARING THE SAME | 2016-12-01 |
20160347881 | Heterogeneous Ziegler-Natta Catalyst Composition, A Process For Its Preparation And A Process For Polymerizing Olefin Using The Same | 2016-12-01 |
20160347882 | Catalyst Process For Spherical Particles | 2016-12-01 |
20160347883 | DISPERSING AGENT FOR SUSPENSION POLYMERIZATION OF VINYL COMPOUND | 2016-12-01 |
20160347884 | SYSTEMS AND PROCESSES FOR MAKING A POLY(VINYL ACETAL) RESIN WITH ENHANCED PARTICLE TRANSPORT AND RECOVERY | 2016-12-01 |
20160347885 | SYSTEMS AND PROCESSES FOR MAKING A POLY(VINYL ACETAL) RESIN WITH ENHANCED PARTICLE TRANSPORT AND RECOVERY | 2016-12-01 |
20160347886 | PRODUCING POLYOLEFIN PRODUCTS WITH IMPROVED STIFFNESS, TOUGHNESS, AND PROCESSABILITY | 2016-12-01 |
20160347887 | Liquid-Solid Sampling System for a Loop Slurry Reactor | 2016-12-01 |
20160347888 | PRODUCING POLYOLEFIN PRODUCTS WITH IMPROVED STIFFNESS, TOUGHNESS, AND PROCESSABILITY | 2016-12-01 |
20160347889 | PRODUCING POLYOLEFIN PRODUCTS | 2016-12-01 |
20160347890 | PRODUCING POLYOLEFIN PRODUCTS | 2016-12-01 |
20160347891 | ETHYLENE/1-BUTENE COPOLYMERS WITH ENHANCED RESIN PROCESSABILITY | 2016-12-01 |